Effect of Hepatitis A vaccination programs for migrant children on the incidence of Hepatitis A in the Netherlands

European Journal of Public Health

Volumn 19, Issue 3, 2009, Pages 240-244

  Suijkerbuijk, Anita W M ^a   Lindeboom, Robert ^b   Van Steenbergen, Jim E ^a   Sonder, Gerard J B ^b,c,d   Doorduyn, Yvonne ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Coordination Center for Travelers Health Advice   (Netherlands)

^d DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

Author keywords

Child; Hepatitis A; Incidence; Risk factors; Vaccination

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; HEALTH PROGRAM; HEPATITIS A; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRANT BIRD; MORBIDITY; NETHERLANDS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; MOROCCO; NETHERLANDS; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 66249089809     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckn145     Document Type: Article

References (19)

1. Koff RS. Hepatitis A. Lancet 1998;351:1643-9.
2. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, et al. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect 2000;124:459-66.
3. Van Der Eerden LJ, Bosnian A, Van Duynhoven YT. Surveillance of hepatitis A in the Netherlands 1993-2002. Ned Tijdschr Geneeskd 2004;148:1390-4.
4. van Gorkom J, Leentvaar-Kuijpers A, Kool JL, Coutinho RA. Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children. Ned Tijdschr Geneeskd 1998;142:1919-23.
5. Richardus JH, Vos D, Veldhuijzen IK, Groen J. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam, J Med Virol 2004;72:197-202.
6. Baaten GG, Sonder GJ, Dukers NH, et al. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol 2007;79:1802-10.
7. Dijkshoorn H, Schilthuis HJ, van den Hoek JA, Verhoeff AP. Travel advice on the prevention of infectious diseases insufficiently obtained by indigenous and non-native inhabitants of Amsterdam, the Netherlands. Ned Tijdschr Geneeskd 2003;147:658-62.
8. Kraaijeveld A. Hepatitis A vaccinatie voor Turkse en Marokkaanse kinderen. Infectieziekten Bull 2002;13:6-7.
9. Timen A. Preventie van hepatitis A als importziekte: een andere aanpak. Infectieziekten Bull 2002;13:3-5.
10. Vrijman K, Hoebe C. JUNI-or hepatitis A vaccinatiemaand groot succes. Infectieziekten Bull 2003;14:418.
11. Sonder GJ, Bovee LP, Baayen TD, et al. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Vaccine 2006;24:4962-8.
12. van Steenbergen JE, Tjon G, van den Hoek A, et al. Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002. J Infect Dis 2004;189:471-82.
13. Tjon G, Xiridou M, Coutinho R, Bruisten S. Different transmission patterns of hepatitis A virus for two main risk groups as evidenced by molecular cluster analysis. J Med Virol 2007;79:488-94.
14. Gezondheidsdienst maakt verboden onderscheid op grond van ras. Commissie Gelijke Behandeling. (MPHS makes a forbidden distinction because of race. Dutch Equal Treatment Commission); 2006.
15. Amato-Gauci A, Ammon A. The First European Communicable Disease Epidemiological Report No. ISBN 978-92-9193-062-3 ISSN 1830-6160. Stockholm: European Centre for Disease prevention and Control, 2007.
16. Previsani N, Lavanchy D. Hepatitis A. Geneva: WHO, 2000.
17. Tosun S, Ertan P, Kasirga E, Atman U. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004;46:669-72.
18. Atabek ME, Fyndyk D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004;67:265-9.
19. Bruisten SM, Tjon GMS, Wijkmans CJ, et al. Moleculaire epidemiologic van hepatitis A in Nederland; het nut van het typeren van geïsoleerde virusstammen. Ned Tijdschr Geneeskd 2007;151:2779-86.